Panel Detail
Monday, November 7, 2011
3:15 PM - 3:40 PM
Presentation - Sabin Vaccine Institute
Sabin Vaccine Institute: Advancing Antipoverty
Vaccine R&D in Innovative Developing Countries
Sabin Vaccine Institute's vaccine R&D and capacity building
in Innovative Developing Countries (IDCs), such as Brazil and
Mexico, is ground-breaking. The Sabin Vaccine Institute Product
Development Partnership's (PDP) 11 years of R&D experience
has produced a well-rounded, low-cost model for developing
novel vaccines to fight such diseases as human hookworm,
schistosomiasis, and Chagas disease. Sabin's PDP model works to
bolster biotechnology capacity of IDCs while advancing solutions
to prevent these poverty-promoting diseases. Recent progress in
vaccine research and strengthening of local partnerships in IDCs
have proven this model works and has potential to be expanded
into other regions and diseases.
Presenter
Peter Hotez, President, Sabin Vaccine Institute
| 
